Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Use of daptomycin for the treatment of methicillin-resistant coagulase-negative staphylococcal ventriculitis.

Erritouni M, Ktaich N, Rahal JJ, Figueroa D, Nieto J, Urban C, Mariano N, Eisinger F, Abayev J, Nicolau D, Rubin D, Raifu M, Segal-Maurer S.

Case Rep Med. 2012;2012:593578. doi: 10.1155/2012/593578. Epub 2012 May 9.

2.

Identification of CTX-M β-lactamases among Escherichia coli from the community in New York City.

Tiruvury H, Johnson JR, Mariano N, Grenner L, Colon-Urban R, Erritouni M, Wehbeh W, Segal-Maurer S, Rahal JJ, Johnston B, Urban C.

Diagn Microbiol Infect Dis. 2012 Mar;72(3):248-52. doi: 10.1016/j.diagmicrobio.2011.11.008. Epub 2012 Jan 17.

PMID:
22257571
3.

Polymyxin-resistant clinical isolates of Escherichia coli.

Urban C, Tiruvury H, Mariano N, Colon-Urban R, Rahal JJ.

Antimicrob Agents Chemother. 2011 Jan;55(1):388-9. doi: 10.1128/AAC.01088-10. Epub 2010 Nov 1.

5.

Identification of CTX-M beta-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilities.

Urban C, Mariano N, Bradford PA, Tuckman M, Segal-Maurer S, Wehbeh W, Grenner L, Colon-Urban R, Johnston B, Johnson JR, Rahal JJ.

Diagn Microbiol Infect Dis. 2010 Apr;66(4):402-6. doi: 10.1016/j.diagmicrobio.2009.11.012.

PMID:
20226330
6.

Antimicrobial resistance among and therapeutic options against gram-negative pathogens.

Rahal JJ.

Clin Infect Dis. 2009 Aug 15;49 Suppl 1:S4-S10. doi: 10.1086/599810.

PMID:
19619021
7.

Health care-associated infection (HAI): a critical appraisal of the emerging threat-proceedings of the HAI Summit.

Kollef MH, Napolitano LM, Solomkin JS, Wunderink RG, Bae IG, Fowler VG, Balk RA, Stevens DL, Rahal JJ, Shorr AF, Linden PK, Micek ST.

Clin Infect Dis. 2008 Oct 1;47 Suppl 2:S55-99; quiz S100-1. doi: 10.1086/590937. Review.

PMID:
18778223
8.

The role of carbapenems in initial therapy for serious Gram-negative infections.

Rahal JJ.

Crit Care. 2008;12 Suppl 4:S5. doi: 10.1186/cc6821. Epub 2008 May 21. Review.

9.

Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long-term care facilities.

Urban C, Bradford PA, Tuckman M, Segal-Maurer S, Wehbeh W, Grenner L, Colon-Urban R, Mariano N, Rahal JJ.

Clin Infect Dis. 2008 Jun 1;46(11):e127-30. doi: 10.1086/588048.

PMID:
18419424
10.

Identification of carbapenem-resistant klebsiella pneumoniae harboring KPC enzymes in New Jersey.

Chiang T, Mariano N, Urban C, Colon-Urban R, Grenner L, Eng RH, Huang D, Dholakia H, Rahal JJ.

Microb Drug Resist. 2007 Winter;13(4):235-39. doi: 10.1089/mdr.2007.767.

PMID:
18184049
11.

Impact of contact and droplet precautions on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus infection.

Mangini E, Segal-Maurer S, Burns J, Avicolli A, Urban C, Mariano N, Grenner L, Rosenberg C, Rahal JJ.

Infect Control Hosp Epidemiol. 2007 Nov;28(11):1261-6. Epub 2007 Sep 18.

PMID:
17926277
12.
13.

Polymyxin B-Resistant Acinetobacter baumannii Clinical Isolate Susceptible to Recombinant BPI and Cecropin P1.

Urban C, Mariano N, Rahal JJ, Tay E, Ponio C, Koprivnjak T, Weiss J.

Antimicrob Agents Chemother. 2001 Mar;45(3):994-5. No abstract available.

14.

Mycobacterial infection as a precursor to sarcoid-like, corticosteroid-responsive, diffuse granulomatous disease.

Terzian C, Rahal JJ.

Int J Infect Dis. 2006 Sep;10(5):407-8. Epub 2006 Feb 3. No abstract available.

15.

Acinetobacter.

Rahal JJ, Urban C.

Semin Respir Crit Care Med. 2000;21(4):341-8.

PMID:
16088745
16.

Fluoroquinolone-resistant Streptococcus agalactiae: epidemiology and mechanism of resistance.

Wehbeh W, Rojas-Diaz R, Li X, Mariano N, Grenner L, Segal-Maurer S, Tommasulo B, Drlica K, Urban C, Rahal JJ.

Antimicrob Agents Chemother. 2005 Jun;49(6):2495-7.

17.

Increased mortality associated with a clonal outbreak of ceftazidime-resistant Klebsiella pneumoniae: a case-control study.

Qavi A, Segal-Maurer S, Mariano N, Urban C, Rosenberg C, Burns J, Chiang T, Maurer J, Rahal JJ.

Infect Control Hosp Epidemiol. 2005 Jan;26(1):63-8.

PMID:
15693410
18.
20.

Effect of interferon-alpha2b therapy on St. Louis viral meningoencephalitis: clinical and laboratory results of a pilot study.

Rahal JJ, Anderson J, Rosenberg C, Reagan T, Thompson LL.

J Infect Dis. 2004 Sep 15;190(6):1084-7. Epub 2004 Aug 10.

PMID:
15319857
21.

Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City.

Bradford PA, Bratu S, Urban C, Visalli M, Mariano N, Landman D, Rahal JJ, Brooks S, Cebular S, Quale J.

Clin Infect Dis. 2004 Jul 1;39(1):55-60. Epub 2004 Jun 14.

PMID:
15206053
22.

Quinolone-resistant Haemophilus influenzae in a long-term care facility: clinical and molecular epidemiology.

Nazir J, Urban C, Mariano N, Burns J, Tommasulo B, Rosenberg C, Segal-Maurer S, Rahal JJ.

Clin Infect Dis. 2004 Jun 1;38(11):1564-9. Epub 2004 May 12.

PMID:
15156444
23.

An outbreak of domestically acquired typhoid fever in Queens, NY.

Yoon J, Segal-Maurer S, Rahal JJ.

Arch Intern Med. 2004 Mar 8;164(5):565-7.

PMID:
15006835
24.
25.

Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii.

Urban C, Segal-Maurer S, Rahal JJ.

Clin Infect Dis. 2003 May 15;36(10):1268-74. Epub 2003 May 1.

PMID:
12746772
26.
27.

Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro.

Anderson JF, Rahal JJ.

Emerg Infect Dis. 2002 Jan;8(1):107-8. No abstract available.

28.

Short-term therapy for intravascular catheter-related Staphylococcus aureus bacteremia.

Rahal JJ.

Clin Infect Dis. 2001 Dec 1;33(11):1946-7; author reply 1949-51. No abstract available.

PMID:
11692309
29.

Nosocomial transmission of imipenem-resistant Pseudomonas aeruginosa following bronchoscopy associated with improper connection to the Steris System 1 processor.

Sorin M, Segal-Maurer S, Mariano N, Urban C, Combest A, Rahal JJ.

Infect Control Hosp Epidemiol. 2001 Jul;22(7):409-13.

PMID:
11583207
30.

Extended-spectrum beta-lactamases: how big is the problem?

Rahal JJ.

Clin Microbiol Infect. 2000 Aug;6 Suppl 2:2-6. Review. No abstract available.

31.

Fluoroquinolone-resistant Streptococcus pneumoniae associated with levofloxacin therapy.

Urban C, Rahman N, Zhao X, Mariano N, Segal-Maurer S, Drlica K, Rahal JJ.

J Infect Dis. 2001 Sep 15;184(6):794-8. Epub 2001 Aug 9.

PMID:
11517444
32.

Detection of multiresistant ceftazidime-susceptible Klebsiella pneumoniae isolates lacking TEM-26 after class restriction of cephalosporins.

Urban C, Mariano N, Rahman N, Queenan AM, Montenegro D, Bush K, Rahal JJ.

Microb Drug Resist. 2000 Winter;6(4):297-303.

PMID:
11272258
33.

Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae.

Ahmad M, Urban C, Mariano N, Bradford PA, Calcagni E, Projan SJ, Bush K, Rahal JJ.

Clin Infect Dis. 1999 Aug;29(2):352-5.

PMID:
10476741
34.
35.

Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella.

Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, Mariano N, Marks S, Burns JM, Dominick D, Lim M.

JAMA. 1998 Oct 14;280(14):1233-7.

PMID:
9786372
36.

Intravascular-catheter-related infections.

Rahal JJ.

Lancet. 1998 Jun 6;351(9117):1739. No abstract available.

PMID:
9734922
37.

Mycobacterium tuberculosis specimen contamination revisited: the role of laboratory environmental control in a pseudo-outbreak.

Segal-Maurer S, Kreiswirth BN, Burns JM, Lavie S, Lim M, Urban C, Rahal JJ Jr.

Infect Control Hosp Epidemiol. 1998 Feb;19(2):101-5.

PMID:
9510107
38.
39.

Klebsiella and extended spectrum beta-lactamases.

Urban C, Rahal JJ.

Int J Antimicrob Agents. 1997 Feb;8(1):37-43.

PMID:
18611783
40.

Current perspectives on multidrug-resistant bacteria. Epidemiology and control.

Segal-Maurer S, Urban C, Rahal JJ Jr.

Infect Dis Clin North Am. 1996 Dec;10(4):939-57. Review.

PMID:
8958176
41.

Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin.

Urban C, Mariano N, Mosinka-Snipas K, Wadee C, Chahrour T, Rahal JJ.

J Antimicrob Chemother. 1996 Feb;37(2):361-4.

PMID:
8707748
42.

The data and safety monitoring board and acquired immune deficiency syndrome (AIDS) clinical trials.

DeMets DL, Fleming TR, Whitley RJ, Childress JF, Ellenberg SS, Foulkes M, Mayer KH, O'Fallon J, Pollard RB, Rahal JJ, et al.

Control Clin Trials. 1995 Dec;16(6):408-21.

PMID:
8720018
43.

Quinupristin/dalfopristin (RP 59500) therapy for vancomycin-resistant Enterococcus faecium aortic graft infection: case report.

Sahgal VS, Urban C, Mariano N, Weinbaum F, Turner J, Rahal JJ.

Microb Drug Resist. 1995 Fall;1(3):245-7.

PMID:
9158782
44.

SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients.

Bradford PA, Urban C, Jaiswal A, Mariano N, Rasmussen BA, Projan SJ, Rahal JJ, Bush K.

Antimicrob Agents Chemother. 1995 Apr;39(4):899-905. Erratum in: Antimicrob Agents Chemother 1995 Jul;39(7):1646.

45.

Management of infections caused by antibiotic-resistant Streptococcus pneumoniae.

Rahal JJ.

N Engl J Med. 1994 Dec 29;331(26):1774-5. No abstract available.

PMID:
7984204
46.

Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam.

Go ES, Urban C, Burns J, Kreiswirth B, Eisner W, Mariano N, Mosinka-Snipas K, Rahal JJ.

Lancet. 1994 Nov 12;344(8933):1329-32.

PMID:
7968028
47.

Mycobacterium-avium complex.

Rubin DS, Rahal JJ.

Infect Dis Clin North Am. 1994 Jun;8(2):413-26. Review.

PMID:
8089468
48.

Identification of TEM-26 beta-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniae.

Urban C, Meyer KS, Mariano N, Rahal JJ, Flamm R, Rasmussen BA, Bush K.

Antimicrob Agents Chemother. 1994 Feb;38(2):392-5.

49.

Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins.

Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ.

Ann Intern Med. 1993 Sep 1;119(5):353-8.

PMID:
8135915
50.

Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus.

Urban C, Go E, Mariano N, Berger BJ, Avraham I, Rubin D, Rahal JJ.

J Infect Dis. 1993 Feb;167(2):448-51.

PMID:
8421178

Supplemental Content

Loading ...
Support Center